Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TALK US Equity

Talkspace, Inc.Health Care · Services-Health Services · CIK 1803901 · FY ends Dec 31
$5.25
+0.00 (+0.00%)
USD · as of 2026-08-14 · marketstack
stale — last close 2026-08-14, not a live quote
3 registered studies · 0 active

Studies where TALK is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

2 interventional · 1 observational · 1 with posted results

Held by 15 tracked-famous managers (Balyasny Asset Management L.P., SOROS FUND MANAGEMENT LLC, Qube Research & Technologies Ltd, RENAISSANCE TECHNOLOGIES LLC, Schonfeld Strategic Advisors LLC, +10 more) · FINRA short interest 3.6 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 5 sells · government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Message-Based Psychotherapy and Digital Treatment Sequences for DepressionNCT04513080results2025-10-30Change in Neuro-QOL - Ability to Participate in Social Roles and ActivitiesRandomized · Single-masked · TreatmentStudy Protocol and Statistical Analysis Plan · Informed Consent FormNot applicableCompletedBehavioral: Video-Chat Psychotherapy (VCP), Message-Based Psychotherapy (MBP), Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy, Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy, High Monetary Incentive (HMI), Low Monetary and Alternative Incentive (LMAI)Study Adherence, Depressive Disorder1,1842024-01-14actual2025-10-30
Comparing Message-based Psychotherapy to Once-weekly, Video-based Psychotherapy for Moderate Depression and AnxietyNCT05467787Change in Patient Health Questionnaire (PHQ-9)Randomized · Single-masked · TreatmentNot applicableCompletedBehavioral: Message-based psychotherapy (MBP), Video-chat Psychotherapy (VCP)Depression, Anxiety832020-11-01actual2023-04-28
Messaging Therapy for Depression and Anxiety: A Longitudinal Effectiveness StudyNCT03699488observationalChange from Baseline in Depressive symptoms on the Patient Health Questionnaire - 9CompletedBehavioral: psychotherapy via asynchronous messageDepressive Symptoms, Anxiety Disorders12,9802018-02-01actual2019-02-06

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19